369 related articles for article (PubMed ID: 36092317)
1. Development of a novel combined nomogram model integrating Rad-score, age and ECOG to predict the survival of patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
Liu A; Liu B; Duan X; Yang B; Wang Y; Dong P; Zhou P
J Gastrointest Oncol; 2022 Aug; 13(4):1889-1897. PubMed ID: 36092317
[TBL] [Abstract][Full Text] [Related]
2. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
[No Abstract] [Full Text] [Related]
3. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
Kong C; Zhao Z; Chen W; Lv X; Shu G; Ye M; Song J; Ying X; Weng Q; Weng W; Fang S; Chen M; Tu J; Ji J
Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
[TBL] [Abstract][Full Text] [Related]
4. A multi-institutional study to predict the benefits of DEB-TACE and molecular targeted agent sequential therapy in unresectable hepatocellular carcinoma using a radiological-clinical nomogram.
Liu K; Zheng X; Lu D; Tan Y; Hou C; Dai J; Shi W; Jiang B; Yao Y; Lu Y; Cao Q; Chen R; Zhang W; Xie J; Chen L; Jiang M; Zhang Z; Liu L; Liu J; Li J; Lv W; Wu X
Radiol Med; 2024 Jan; 129(1):14-28. PubMed ID: 37863847
[TBL] [Abstract][Full Text] [Related]
5. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
Niu XK; He XF
World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
[TBL] [Abstract][Full Text] [Related]
6. A radiomics nomogram for predicting transcatheter arterial chemoembolization refractoriness of hepatocellular carcinoma without extrahepatic metastasis or macrovascular invasion.
Sheen H; Kim JS; Lee JK; Choi SY; Baek SY; Kim JY
Abdom Radiol (NY); 2021 Jun; 46(6):2839-2849. PubMed ID: 33388805
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma.
Shi ZX; Li CF; Zhao LF; Sun ZQ; Cui LM; Xin YJ; Wang DQ; Kang TR; Jiang HJ
Hepatobiliary Pancreat Dis Int; 2024 Aug; 23(4):361-369. PubMed ID: 37429785
[TBL] [Abstract][Full Text] [Related]
8. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
9. MRI-Based Radiomics: Associations With the Recurrence-Free Survival of Patients With Hepatocellular Carcinoma Treated With Conventional Transcatheter Arterial Chemoembolization.
Song W; Yu X; Guo D; Liu H; Tang Z; Liu X; Zhou J; Zhang H; Liu Y; Liu X
J Magn Reson Imaging; 2020 Aug; 52(2):461-473. PubMed ID: 31675174
[TBL] [Abstract][Full Text] [Related]
10. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
[TBL] [Abstract][Full Text] [Related]
11.
Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive assessment of response to transcatheter arterial chemoembolization for hepatocellular carcinoma with the deep neural networks-based radiomics nomogram.
Liu Y; Liu Z; Li X; Zhou W; Lin L; Chen X
Acta Radiol; 2024 Jun; 65(6):535-545. PubMed ID: 38489805
[TBL] [Abstract][Full Text] [Related]
13. A Radiomics Nomogram for Preoperative Prediction of Early Recurrence of Small Hepatocellular Carcinoma After Surgical Resection or Radiofrequency Ablation.
Wen L; Weng S; Yan C; Ye R; Zhu Y; Zhou L; Gao L; Li Y
Front Oncol; 2021; 11():657039. PubMed ID: 34026632
[TBL] [Abstract][Full Text] [Related]
14. Radiomics Analysis on Multiphase Contrast-Enhanced CT: A Survival Prediction Tool in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Meng XP; Wang YC; Ju S; Lu CQ; Zhong BY; Ni CF; Zhang Q; Yu Q; Xu J; Ji J; Zhang XM; Tang TY; Yang G; Zhao Z
Front Oncol; 2020; 10():1196. PubMed ID: 32850345
[TBL] [Abstract][Full Text] [Related]
15. Radiomics-based nomogram as predictive model for prognosis of hepatocellular carcinoma with portal vein tumor thrombosis receiving radiotherapy.
Huang YM; Wang TE; Chen MJ; Lin CC; Chang CW; Tai HC; Hsu SM; Chen YJ
Front Oncol; 2022; 12():906498. PubMed ID: 36203419
[TBL] [Abstract][Full Text] [Related]
16. Radiomics nomogram for the prediction of microvascular invasion of HCC and patients' benefit from postoperative adjuvant TACE: a multi-center study.
Zhang K; Zhang L; Li WC; Xie SS; Cui YZ; Lin LY; Shen ZW; Zhang HM; Xia S; Ye ZX; He K; Shen W
Eur Radiol; 2023 Dec; 33(12):8936-8947. PubMed ID: 37368104
[TBL] [Abstract][Full Text] [Related]
17. Prediction of initial objective response to drug-eluting beads transcatheter arterial chemoembolization for hepatocellular carcinoma using CT radiomics-based machine learning model.
Zhang X; He Z; Zhang Y; Kong J
Front Pharmacol; 2024; 15():1315732. PubMed ID: 38344175
[No Abstract] [Full Text] [Related]
18. A radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma.
Zhu Y; Weng S; Li Y; Yan C; Ye R; Wen L; Zhou L; Gao L
Abdom Radiol (NY); 2021 Jul; 46(7):3139-3148. PubMed ID: 33641018
[TBL] [Abstract][Full Text] [Related]
19. Radiomics nomogram for prediction of glypican-3 positive hepatocellular carcinoma based on hepatobiliary phase imaging.
Zhang N; Wu M; Zhou Y; Yu C; Shi D; Wang C; Gao M; Lv Y; Zhu S
Front Oncol; 2023; 13():1209814. PubMed ID: 37841420
[TBL] [Abstract][Full Text] [Related]
20. Radiomics Analysis Based on Contrast-Enhanced MRI for Prediction of Therapeutic Response to Transarterial Chemoembolization in Hepatocellular Carcinoma.
Zhao Y; Wang N; Wu J; Zhang Q; Lin T; Yao Y; Chen Z; Wang M; Sheng L; Liu J; Song Q; Wang F; An X; Guo Y; Li X; Wu T; Liu AL
Front Oncol; 2021; 11():582788. PubMed ID: 33868988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
